Evidence mapPaperPMID 35867321Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2023

A qualitative study to examine meaningful change in physical function associated with weight-loss.

Jiat-Ling Poon, Chris Marshall, Chloe Johnson, Hannah C Pegram, Maile Hunter, Hongjun Kan, Nadia N Ahmad

Abstract read
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiat-Ling PoonValue, Evidence, and Outcomes Center of Innovation, Eli Lilly and Company, Indianapolis, IN, USA. jlpoon@lilly.com.ORCID http://orcid.org/0000-0001-7038-2102
Chris MarshallClinical Outcomes Assessment, Clarivate Analytics, London, UK.ORCID http://orcid.org/0000-0003-1486-8997
Chloe JohnsonClinical Outcomes Assessment, Clarivate Analytics, London, UK.ORCID http://orcid.org/0000-0002-2278-2176
Hannah C PegramClinical Outcomes Assessment, Clarivate Analytics, London, UK.ORCID http://orcid.org/0000-0002-4446-4531
Maile HunterFormerly of Clinical Outcomes Assessment, Clarivate Analytics, Nashville, TN, USA.
Hongjun KanValue, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-4585-5016
Nadia N AhmadLilly Diabetes, Eli Lilly and Company, Indianapolis, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study explored perceptions of meaningful weight-loss and the level of change on two patient-reported outcome (PRO) measures, the 36-item Short Form Health Survey® [SF-36v2®] and Impact of Weight on Quality of Life Lite-Clinical Trials

methodsThirty-three qualitative interviews were conducted in the US with adults living with overweight or obesity. Concept elicitation explored perceptions of minimally important/meaningful weight-loss using open-ended questions. Cognitive debriefing was used to understand thresholds for meaningful change on both measures.

resultsMost participants (n = 23/33) expected a 5% total body weight-loss to yield some benefit in physical functioning, while all participants expected a 10% weight-loss to provide a meaningful and noticeable improvement in their physical functioning. Participants indicated that an item-level 1-point score change on each measure would represent a noticeable improvement in physical functioning and indicate treatment success.

conclusionsParticipants expected moderate weight-losses to be noticeable, with ≥ 10% weight-loss yielding the most consistent results. The findings suggested that both measures provide strong opportunity to demonstrate treatment benefit in relation to physical functioning as a small change on the response scale would represent a noticeable improvement in participants' daily lives.

Indexed as

OverweightQuality of LifeAdultHumansObesityTreatment OutcomeWeight LossAdultsObesityPhysical activityQuality of life

Identifiers

PMID35867321
PMCPMC9305034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.